A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical trial NCT07441642 · RECRUITING
Trial details
- NCT number
- NCT07441642
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2029-08-21
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.